Early Molecular Response (EMR) with Frontline Treatment Is a Significant Predictor of Long-Term BCR-ABL Transcript Levels in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML) in Chronic Phase
- Resource Type
- Abstract
- Source
- In
Blood 3 December 2015 126(23):1579-1579 - Subject
- Language
- ISSN
- 0006-4971